Nu-Med Plus (NUMD) Total Current Liabilities (2011 - 2025)
Nu-Med Plus (NUMD) posted Total Current Liabilities of $279189.0 for Q4 2025, up 5.87% sequentially from $263708.0 in Q3 2025, and up 24.38% YoY from $224469.0 in Q4 2024.
Nu-Med Plus (NUMD) Total Current Liabilities (2011 - 2025) Analysis & Trends
Nu-Med Plus has reported Total Current Liabilities for 15 years, with the latest figure at $279189.0 in Q4 2025.
- Quarterly Total Current Liabilities rose 24.38% year-over-year to $279189.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $279189.0 (up 24.38% YoY) and the FY2025 annual result came in at $279189.0, up 24.38% from the prior year.
- Total Current Liabilities improved to $279189.0 in Q4 2025 per NUMD's latest filing, from $263708.0 in the prior quarter.
- Over five years, Total Current Liabilities peaked at $279189.0 in Q4 2025 and troughed at $84674.0 in Q1 2021.
- A 5-year average of $188808.2 and a median of $187249.0 in 2024 frame the typical range for Total Current Liabilities.
- The sharpest annual moves came in 2021 and 2022: Total Current Liabilities tumbled 79.57% in 2021, then soared 181.47% in 2022.
- Over 5 years, Total Current Liabilities stood at $154521.0 in 2021, then declined by 7.73% to $142570.0 in 2022, then climbed by 12.37% to $160207.0 in 2023, then jumped by 40.11% to $224469.0 in 2024, then rose by 24.38% to $279189.0 in 2025.
- According to Business Quant data, Total Current Liabilities over the past three periods registered $279189.0, $263708.0, and $254857.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.20 Bn | 193.60 Bn | 7.27 Bn | 17.81 Bn |
| 2 | Stryker | 127.66 Bn | 124.19 Bn | 4.50 Bn | 6.68 Bn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 11.66 Bn |
| 4 | Boston Scientific | 73.25 Bn | 72.71 Bn | 3.85 Bn | 6.43 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 1.51 Bn |
| 6 | Dexcom | 34.37 Bn | 32.42 Bn | 830.00 Mn | 2.36 Bn |
| 7 | GE HealthCare Technologies | 33.89 Bn | 31.78 Bn | 2.18 Bn | 8.30 Bn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 8.63 Bn |
| 9 | Steris | 23.03 Bn | 22.55 Bn | 684.20 Mn | 1.28 Bn |
| 10 | Nu-Med Plus | 2.03 Mn | 2.02 Mn | - | 280,395.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 279,189.00 |
| Sep 30, 2025 | 263,708.00 |
| Jun 30, 2025 | 254,857.00 |
| Mar 31, 2025 | 240,202.00 |
| Dec 31, 2024 | 224,469.00 |
| Sep 30, 2024 | 211,382.00 |
| Jun 30, 2024 | 196,905.00 |
| Mar 31, 2024 | 177,593.00 |
| Dec 31, 2023 | 160,207.00 |
| Sep 30, 2023 | 145,703.00 |
| Jun 30, 2023 | 152,096.00 |
| Mar 31, 2023 | 150,298.00 |
| Dec 31, 2022 | 142,570.00 |
| Sep 30, 2022 | 273,299.00 |
| Jun 30, 2022 | 255,521.00 |
| Mar 31, 2022 | 196,937.00 |
| Dec 31, 2021 | 154,521.00 |
| Sep 30, 2021 | 121,253.00 |
| Jun 30, 2021 | 90,781.00 |
| Mar 31, 2021 | 84,674.00 |